
Autolus Therapeutics plc
USD1.62
-0.13 (-7.43%)
CEO
Christian Martin Itin
IPO Date
2018-06-22
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
GB
Open
$1.78
Prev. Close
$1.75
Day Low
$1.59
Day High
$1.78
52W Low
$1.18
52W High
$2.70
Market Cap
$0.43B
Volume
2.05M
Autolus Therapeutics to Report Second Quarter 2021 Financial Results on August 5, 2021, and will Participate in the William Blair Biotech Focus Conference 2021 on July 14, 2021